Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Inflammatory Bowel Disease and the Risk of Autoimmune Diseases.

Wilson JC, Furlano RI, Jick SS, Meier CR.

J Crohns Colitis. 2016 Feb;10(2):186-93. doi: 10.1093/ecco-jcc/jjv193. Epub 2015 Oct 27.

PMID:
26507860
2.

A population-based study examining the risk of malignancy in patients diagnosed with inflammatory bowel disease.

Wilson JC, Furlano RI, Jick SS, Meier CR.

J Gastroenterol. 2016 Nov;51(11):1050-1062. Epub 2016 Apr 7.

PMID:
27056729
3.

Increased risk of pneumonia among patients with inflammatory bowel disease.

Long MD, Martin C, Sandler RS, Kappelman MD.

Am J Gastroenterol. 2013 Feb;108(2):240-8. doi: 10.1038/ajg.2012.406. Epub 2013 Jan 8.

4.

Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease.

Gupta G, Lautenbach E, Lewis JD.

Clin Gastroenterol Hepatol. 2006 Dec;4(12):1483-90.

PMID:
17162240
5.

Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern california-managed care organization.

Weng X, Liu L, Barcellos LF, Allison JE, Herrinton LJ.

Am J Gastroenterol. 2007 Jul;102(7):1429-35. Epub 2007 Apr 16.

PMID:
17437504
6.

Prognosis after first-time myocardial infarction in patients with inflammatory bowel disease according to disease activity: nationwide cohort study.

Kristensen SL, Ahlehoff O, Lindhardsen J, Erichsen R, Lamberts M, Khalid U, Nielsen OH, Torp-Pedersen C, Gislason GH, Hansen PR.

Circ Cardiovasc Qual Outcomes. 2014 Nov;7(6):857-62. doi: 10.1161/CIRCOUTCOMES.114.000918. Epub 2014 Oct 14.

PMID:
25316773
7.

Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease: a case-control study.

Ricart E, Panaccione R, Loftus EV Jr, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ.

Inflamm Bowel Dis. 2004 May;10(3):207-14.

PMID:
15290913
8.

Incidence, management, and course of cancer in patients with inflammatory bowel disease.

Algaba A, Guerra I, Marín-Jiménez I, Quintanilla E, López-Serrano P, García-Sánchez MC, Casis B, Taxonera C, Moral I, Chaparro M, Martín-Rodríguez D, Martín-Arranz MD, Manceñido N, Menchén L, López-Sanromán A, Castaño Á, Bermejo F.

J Crohns Colitis. 2015 Apr;9(4):326-33. doi: 10.1093/ecco-jcc/jjv032. Epub 2015 Feb 16.

PMID:
25687203
9.

Inflammatory bowel disease and cervical neoplasia: a population-based nationwide cohort study.

Rungoe C, Simonsen J, Riis L, Frisch M, Langholz E, Jess T.

Clin Gastroenterol Hepatol. 2015 Apr;13(4):693-700.e1. doi: 10.1016/j.cgh.2014.07.036. Epub 2014 Jul 30.

PMID:
25086189
10.

The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study.

Bernstein CN, Wajda A, Blanchard JF.

Clin Gastroenterol Hepatol. 2008 Jan;6(1):41-5. Epub 2007 Dec 11.

PMID:
18063423
11.

Prenatal and perinatal characteristics associated with pediatric-onset inflammatory bowel disease.

Hutfless S, Li DK, Heyman MB, Bayless TM, Abramson O, Herrinton LJ.

Dig Dis Sci. 2012 Aug;57(8):2149-56. doi: 10.1007/s10620-012-2128-1. Epub 2012 Mar 24.

12.

Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease.

Long MD, Herfarth HH, Pipkin CA, Porter CQ, Sandler RS, Kappelman MD.

Clin Gastroenterol Hepatol. 2010 Mar;8(3):268-74. doi: 10.1016/j.cgh.2009.11.024. Epub 2010 Jan 16.

13.

Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study.

Rungoe C, Basit S, Ranthe MF, Wohlfahrt J, Langholz E, Jess T.

Gut. 2013 May;62(5):689-94. doi: 10.1136/gutjnl-2012-303285. Epub 2012 Sep 8.

PMID:
22961677
14.

The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study.

Baars JE, Looman CW, Steyerberg EW, Beukers R, Tan AC, Weusten BL, Kuipers EJ, van der Woude CJ.

Am J Gastroenterol. 2011 Feb;106(2):319-28. doi: 10.1038/ajg.2010.428. Epub 2010 Nov 2. Erratum in: Am J Gastroenterol. 2014 May;109(5):781-2.

PMID:
21045815
15.

Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.

Jess T, Simonsen J, Jørgensen KT, Pedersen BV, Nielsen NM, Frisch M.

Gastroenterology. 2012 Aug;143(2):375-81.e1; quiz e13-4. doi: 10.1053/j.gastro.2012.04.016. Epub 2012 Apr 19.

PMID:
22522090
16.

Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study.

Kappelman MD, Horvath-Puho E, Sandler RS, Rubin DT, Ullman TA, Pedersen L, Baron JA, Sørensen HT.

Gut. 2011 Jul;60(7):937-43. doi: 10.1136/gut.2010.228585. Epub 2011 Feb 21.

PMID:
21339206
17.

Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease.

Herrinton LJ, Liu L, Weng X, Lewis JD, Hutfless S, Allison JE.

Am J Gastroenterol. 2011 Dec;106(12):2146-53. doi: 10.1038/ajg.2011.283. Epub 2011 Oct 25.

PMID:
22031357
18.

5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study.

van Staa TP, Card T, Logan RF, Leufkens HG.

Gut. 2005 Nov;54(11):1573-8. Epub 2005 Jun 30. Review.

19.

Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease.

Long MD, Martin C, Sandler RS, Kappelman MD.

Aliment Pharmacol Ther. 2013 Feb;37(4):420-9. doi: 10.1111/apt.12182. Epub 2012 Dec 13.

20.

Factors associated with readmissions and outcomes of patients hospitalized for inflammatory bowel disease.

Nguyen GC, Bollegala N, Chong CA.

Clin Gastroenterol Hepatol. 2014 Nov;12(11):1897-1904.e1. doi: 10.1016/j.cgh.2014.02.042. Epub 2014 Mar 26.

PMID:
24681074

Supplemental Content

Support Center